| EBV | Epstein-Barr virus |
| LMPs | Latent membrane proteins |
| EBNAs | Epstein-Barr virus nuclear antigens |
| NPC | Nasopharyngeal carcinoma |
| IKK | Inhibitory-κB kinase |
| NF-κB | Nuclear factor kappa B |
| CTARs | C-terminal activation regions |
| STAT | Signal transducer and activator of transcription |
| PI3K | Phosphatidylinositol 3-kinase |
| BL | Burkitt’s lymphoma |
| UICC | Union for International Cancer Control |
| AJCC | American Joint Committee on Cancer |
| TNM | Tumor, node, and metastasis |
| JAK | Janus kinase |
| mTOR | Mammalian target of rapamycin |
| EGFR | Epidermal growth factor receptor |
| MAPK | Mitogen-activated protein kinase |
| NHLs | Non-Hodgkin’s lymphomas |
| TCLs | T-cell lymphomas |
| PTCLs | Peripheral T-cell lymphomas |
| CTCLs | Cutaneous T-cell lymphomas |
| AITL | Angioimmunoblastic T-cell lymphoma |
| PD-L1 | Programmed death-ligand 1 |
| PTEN | Phosphatase and tensin homolog |
| CDKN2 | Cyclin-dependent kinase inhibitor 2 |
| Myc | Master regulator of cell cycle entry and proliferative metabolism |
| Bcl-2 | B-cell lymphoma 2 |
| Mdm2 | Mouse double minute 2 homolog |
| USP7 | Ubiquitin-specific-processing protease 7 |
| TRAF2 | Tumor necrosis factor receptor-associated factor 2 |
| DNMT1 | DNA methyltransferase 1 |
| DKK1 | Dickkopf protein family |